EUVIMEDEUVIMED entdecken
Crossref

Staged I-125 Eye Plaque Brachytherapy for the Treatment of Large Uveal Melanoma: A Single Institution Experience

Kevin Tran, Amy C Schefler, Lindsey N Nguyen, Devin Olek, Hui-Chuan Wang, Ramiro Pino, Edward Brian Butler, Bin S Teh

Practical Radiation Oncology · 2026

DOI: 10.1016/j.prro.2025.06.003 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Practical Radiation Oncology, 2026. Verfasst von Kevin Tran und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Houston Methodist Hospital, Houston, Texas. Hauptthemen laut MEDLINE: Melanoma, Brachytherapy, Uveal Neoplasms, Iodine Radioisotopes. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Eye plaque brachytherapy (EPBT) is not routinely performed on large uveal melanomas (UM) as commercially available plaques often cannot ensure adequate coverage of the tumor with high doses of 85 Gy. The purpose of this study is to report our institution's experience with a clinically novel approach of staged EPBT in treating large UM in 2 treatments, 45 Gy in each treatment. METHODS AND MATERIALS: Patients were included if they underwent staged EPBT at our institution between 2020 and 2023. RESULTS: A total of 13 patients with a median age of 65 were included in this study. All patients were treated with Iodine-125 with a first-stage prescription dose of 45 Gy and with a second-stage treatment occurring at median 13 weeks after with prescription dose of 45 Gy. Median follow-up was 42 months, and local control was 100% with no patients requiring an enucleation for a local recurrence or other radiation-related toxicities. At last follow-up, all tumors were decreased in size. Visual acuity worsened in 11 patients, and other radiation-related toxicities included cataract, cystoid macular edema, radiation retinopathy, and neovascular glaucoma. Three patients developed metastases, one of whom died shortly after, while all other patients were alive at last follow-up. CONCLUSIONS: Staged EPBT for large UM is a novel and feasible globe-preserving treatment with a high rate of local control. Ocular toxicities are expected but do not require enucleation. Further prospective randomized trials should be performed to validate this treatment approach.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MelanomaBrachytherapyUveal NeoplasmsIodine RadioisotopesHumansUveal MelanomaMaleAgedFemaleMiddle AgedAged, 80 and overRadiotherapy DosageAdult

Substanzen

Iodine RadioisotopesIodine-125

Autor:innen und Institutionen

  • Department of Radiation Oncology, Houston Methodist Hospital, Houston, Texas.
  • Retina Consultants of Texas, Houston, Texas.
  • Department of Radiation Oncology, Houston Methodist Hospital, Houston, Texas. Electronic address: BTeh@houstonmethodist.org.

Zitieren

APA

Tran, K., Schefler, A. C., Nguyen, L. N., Olek, D., Wang, H. C., Pino, R., Butler, E. B., & Teh, B. S. (2026). Staged I-125 Eye Plaque Brachytherapy for the Treatment of Large Uveal Melanoma: A Single Institution Experience. Practical Radiation Oncology. https://doi.org/10.1016/j.prro.2025.06.003

Vancouver

Tran K, Schefler AC, Nguyen LN, Olek D, Wang HC, Pino R, et al. Staged I-125 Eye Plaque Brachytherapy for the Treatment of Large Uveal Melanoma: A Single Institution Experience. Practical Radiation Oncology. 2026. doi:10.1016/j.prro.2025.06.003

BibTeX
@article{Tran2026,
  author = {Tran, Kevin and Schefler, Amy C and Nguyen, Lindsey N and Olek, Devin and Wang, Hui-Chuan and Pino, Ramiro and Butler, Edward Brian and Teh, Bin S},
  title = {Staged I-125 Eye Plaque Brachytherapy for the Treatment of Large Uveal Melanoma: A Single Institution Experience},
  journal = {Practical Radiation Oncology},
  year = {2026},
  doi = {10.1016/j.prro.2025.06.003}
}
Kostenlos starten →